CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net (loss) income	$ (155,677)	$ 483,436
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	6,701	6,661
Reduction in carrying amount of right-of-use assets	4,126	4,320
Credit losses and sales allowances	(44)	438
Deferred taxes	(278,067)	(530,628)
Release of liabilities for unrecognized tax benefits	(73)	(102)
Share-based compensation expense	38,412	33,049
Digital asset impairment losses	371,723	43,054
Amortization of issuance costs on long-term debt	6,399	4,400
Gain on debt extinguishment	0	(44,686)
Changes in operating assets and liabilities:
Accounts receivable	20,119	17,737
Prepaid expenses and other current assets	7,914	4,861
Deposits and other assets	(8,163)	1,189
Accounts payable and accrued expenses	(8,164)	(9,400)
Accrued compensation and employee benefits	(18,059)	(15,559)
Accrued interest	3,641	(1,336)
Deferred revenue and advance payments	24,994	26,952
Operating lease liabilities	(5,467)	(5,233)
Other long-term liabilities	(5,057)	(228)
Net cash provided by operating activities	5,258	18,925
Investing activities:
Purchases of digital assets	(2,433,137)	(526,278)
Purchases of property and equipment	(2,268)	(1,138)
Net cash used in investing activities	(2,435,405)	(527,416)
Financing activities:
Proceeds from convertible senior notes	2,203,750	0
Payments to settle conversions of convertible senior notes	(44)	0
Repayments of secured term loan and third-party extinguishment costs	0	(160,033)
Repayments of other long-term secured debt	(266)	(254)
Proceeds from sale of common stock under public offerings	137,765	676,068
Issuance costs paid related to sale of common stock under public offerings	(613)	(3,628)
Proceeds from exercise of stock options	153,349	12,104
Payment of withholding tax on vesting of restricted stock units	(2,173)	(726)
Net cash provided by financing activities	2,451,831	525,911
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	(1,556)	(235)
Net increase in cash, cash equivalents, and restricted cash	20,128	17,185
Cash, cash equivalents, and restricted cash, beginning of period	48,673	50,868
Cash, cash equivalents, and restricted cash, end of period	68,801	68,053
Convertible Senior Notes
Financing activities:
Issuance costs paid for convertible senior notes	(42,008)	0
Employee Stock Purchase Plan
Financing activities:
Proceeds from sales under employee stock purchase plan	$ 2,071	$ 2,380